We are live on
!
Find out more
Acadia Pharmaceuticals
ACAD
ACAD
232 hedge funds and large institutions have $2.97B invested in Acadia Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 76 increasing their positions, 70 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
143% more call options, than puts
Call options by funds: $10.9M | Put options by funds: $4.48M
25% more first-time investments, than exits
New positions opened: 35 | Existing positions closed: 28
8% more capital invested
Capital invested by funds: $2.75B → $2.97B (+$224M)
2% more funds holding
Funds holding: 227 → 232 (+5)
9% more repeat investments, than reductions
Existing positions increased: 76 | Existing positions reduced: 70
0.79% more ownership
Funds ownership: 96.21% → 97% (+0.79%)
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
Holders
232
Holders Change
+5
Holders Change %
+2.2%
% of All Funds
3.7%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.08%
New
35
Increased
76
Reduced
70
Closed
28
Calls
$10.9M
Puts
$4.48M
Net Calls
+$6.39M
Net Calls Change
-$939K
Top Buyers
| 1 |
RI
RTW Investments
New York
|
+$87.1M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
+$23.3M |
| 3 |
Morgan Stanley
New York
|
+$22.3M |
| 4 |
D.E. Shaw & Co
New York
|
+$13M |
| 5 |
PAMS
Pictet Asset Management (Switzerland)
Geneva 73,
Switzerland
|
+$11M |
Top Sellers
| 1 |
State Street
Boston,
Massachusetts
|
-$41M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$28.3M |
| 3 |
B
Braidwell
Stamford,
Connecticut
|
-$23.8M |
| 4 |
Man Group
London,
United Kingdom
|
-$18.2M |
| 5 |
BCLSI
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
-$11.2M |
